Safety and Efficiency of Repeat Salvage Lymph Node Dissection for Recurrence of Prostate Cancer Using PSMA-Radioguided Surgery (RGS) after Prior Salvage Lymph Node Dissection with or without Initial RGS Support - Beyond the Abstract

October 25, 2023

Approximately, one out of five patients develop biochemical recurrence after radical prostatectomy for localized prostate cancer within four years. In consecutive PSMA PET/CT, a relevant subset of these patients present with oligo-recurrent disease. In these patients, PSMA-targeted radioguided surgery (RGS) has been proven effective for removing cancerous tissue leading to consecutive PSA responses.

Biographies:

Fabian Falkenbach, MD, Martini-Klinik Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany

Sophie Knipper, MD, Martini-Klinik Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany

Tobias Maurer, MD, FEBU, Martini-Klinik Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany